The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro ...

Drugs included on the List of Drugs for Exceptional Importation and Sale would be eligible for exceptional importation and sale as per sections C.10.004 to C.10.013 of the proposed amendments to the ...

The List of Drugs for the Purposes of Section C.01.014.84, also known as the Safety Stock List, would specify drugs subject to the safety stock requirements as per sections C.01.014.84 and C.01.014.85 ...

The Central Drugs Standard Control Organisation (CDSCO) has listed select batches of 145 drugs and formulations, including medications for hypertension, allergies and nausea, as not of standard ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...

Incorrect dosing can cause severe side effects, so it is essential to take the drug as a doctor instructs. It is also critical to take oral chemotherapy drugs according to the exact schedule that ...

We do not include minor changes, such as editorial corrections. We consider drugs and equipment for a medical emergency when we review if a practice is safe. This relates to: Regulation 12: Safe care ...

Last week, the FDA officially moved Ozempic and Wegovy off its shortage list four months after the drug was found to available in the U.S. During the time that semaglutide has been on the list ...

Drug compounders sued the US Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's weight-loss and diabetes treatments Wegovy and Ozempic from its shortage list, ...